Familial atypical hemolytic uremic syndrome with positive p.S1191L (c.3572C>T) mutation on the CFH gene: A single-center experience

1Fakhouri F, Zuber J, Frémeaux-Bacchi V, Loirat C. Haemolytic uraemic syndrome. Lancet. 2017; 390(10095): 681-696.Fakhouri F Zuber J Frémeaux-Bacchi V Loirat C Haemolytic uraemic syndrome Lancet 2017 390 10095 681 69610.1016/S0140-6736(17)30062-4Search in Google Scholar

2Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, et al. Atypical hemolytic-uremic syndrome: An update on pathophysiology, diagnosis, and treatment. Ther Apher Dial. 2019; 23(1): 4-21.Raina R Krishnappa V Blaha T Kann T Hein W Burke L et al Atypical hemolytic-uremic syndrome: An update on pathophysiology, diagnosis, and treatment Ther Apher Dial 2019 23 1 4 2110.1111/1744-9987.1276330294946Search in Google Scholar

3Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009; 361(17): 1676-1687.Noris M Remuzzi G Atypical hemolytic-uremic syndrome N Engl J Med 2009 361 17 1676 168710.1056/NEJMra090281419846853Search in Google Scholar

4Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347(8): 589-600.Moake JL Thrombotic microangiopathies N Engl J Med 2002 347 8 589 60010.1056/NEJMra02052812192020Search in Google Scholar

5Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol. 2010; 5(19): 1844-1859.Noris M Caprioli J Bresin E Mossali C Pianetti G Gamba S et al Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype Clin J Am Soc Nephrol 2010 5 19 1844 185910.2215/CJN.02210310297438620595690Search in Google Scholar

6Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010; 21(12): 2180-2187.Dragon-Durey MA Sethi SK Bagga A Blanc C Blouin J Ranchin B et al Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome J Am Soc Nephrol 2010 21 12 2180 218710.1681/ASN.2010030315301403121051740Search in Google Scholar

7Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, et al. Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006; 108(4): 1267-1279.Caprioli J Noris M Brioschi S Pianetti G Castelletti F Bettinaglio P et al Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 2006 108 4 1267 127910.1182/blood-2005-10-007252189587416621965Search in Google Scholar

8Caprioli J, Bettinaglio P, Zipfel PF, Amadei B, Daina E, Gamba S, et al. The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat. J Am Soc Nephrol. 2001; 12(2): 297-307.Caprioli J Bettinaglio P Zipfel PF Amadei B Daina E Gamba S et al The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat J Am Soc Nephrol 2001 12 2 297 30710.1681/ASN.V12229711158219Search in Google Scholar

9Herbert AP, Kavanagh D, Johansson C, Morgan HP, Blaum BS, Hannan JP, et al. Structural and functional characterization of the product of disease-related factor H gene conversion. Biochemistry. 2012; 51(9): 1874-1884.Herbert AP Kavanagh D Johansson C Morgan HP Blaum BS Hannan JP et al Structural and functional characterization of the product of disease-related factor H gene conversion Biochemistry 2012 51 9 1874 188410.1021/bi201689j22320225Search in Google Scholar

10Perez-Caballero D, Gonzalez-Rubio C, Gallardo ME, Vera M, López-Trascasa M, Rodríguez de Córdoba S, et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am J Hum Genet. 2001; 68(2): 478-484.Perez-Caballero D Gonzalez-Rubio C Gallardo ME Vera M López-Trascasa M Rodríguez de Córdoba S et al Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome Am J Hum Genet 2001 68 2 478 48410.1086/318201123528011170895Search in Google Scholar

11Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013; 8(4): 554-562.Fremeaux-Bacchi V Fakhouri F Garnier A Bienaimé F Dragon-Durey MA Ngo S et al Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults Clin J Am Soc Nephrol 2013 8 4 554 56210.2215/CJN.04760512361394823307876Search in Google Scholar

12Schönauer R, Seidel A, Grohmann M, Lindner TH, Bergmann C, Halbritter J. Deleterious impact of a novel CFH splice site variant in atypical hemolytic uremic syndrome. Front Genet. 2019; 10: 465-471.Schönauer R Seidel A Grohmann M Lindner TH Bergmann C Halbritter J Deleterious impact of a novel CFH splice site variant in atypical hemolytic uremic syndrome Front Genet 2019 10 465 47110.3389/fgene.2019.00465653024831156713Search in Google Scholar

13Venables JP, Strain L, Routledge D, Bourn D, Powell HM, Warwicker P, et al. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Med. 2006; 3(10): e431-e442.Venables JP Strain L Routledge D Bourn D Powell HM Warwicker P et al Atypical haemolytic uraemic syndrome associated with a hybrid complement gene PLoS Med 2006 3 10 e431 e44210.1371/journal.pmed.0030431162655617076561Search in Google Scholar

14Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum Mutat. 2006; 27(3): 292-293.Heinen S Sanchez-Corral P Jackson MS Strain L Goodship JA Kemp EJ et al De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome Hum Mutat 2006 27 3 292 29310.1002/humu.940816470555Search in Google Scholar

15Vaziri-Sani F, Holmberg L, Sjöholm AG, Kristoffersson AC, Manea M, Frémeaux-Bacchi V. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney Int. 2006; 69(6): 981-988.Vaziri-Sani F Holmberg L Sjöholm AG Kristoffersson AC Manea M Frémeaux-Bacchi V Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome Kidney Int 2006 69 6 981 98810.1038/sj.ki.500015516528247Search in Google Scholar

16Richards A, Buddles MR, Donne RL, Kaplan BS, Kirk E, Venning MC, et al. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet. 2001; 68(2): 485-490.Richards A Buddles MR Donne RL Kaplan BS Kirk E Venning MC et al Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition Am J Hum Genet 2001 68 2 485 49010.1086/318203123528111170896Search in Google Scholar

17Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, Vigneau C, Kuypers D, Boudailliez B, et al. Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet. 2004;41(6): e84-e90.Fremeaux-Bacchi V Dragon-Durey MA Blouin J Vigneau C Kuypers D Boudailliez B et al Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome J Med Genet 200441 6 e84 e9010.1136/jmg.2004.019083173582215173250Search in Google Scholar

18Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2006; 17(7): 2017-2025.Fremeaux-Bacchi V Moulton EA Kavanagh D Dragon-Durey MA Blouin J Caudy A et al Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome J Am Soc Nephrol 2006 17 7 2017 202510.1681/ASN.200510105116762990Search in Google Scholar

19Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Arranz EA, Garrido CA, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA. 2007; 104(1): 240-245.Goicoechea de Jorge E Harris CL Esparza-Gordillo J Carreras L Arranz EA Garrido CA et al Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome Proc Natl Acad Sci USA 2007 104 1 240 24510.1073/pnas.0603420103176544217182750Search in Google Scholar

20Hu H, Nagra A, Haq MR, Gilbert RD. Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement. Pediatr Nephrol. 2014; 29(6): 1103-1106.Hu H Nagra A Haq MR Gilbert RD Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement Pediatr Nephrol 2014 29 6 1103 110610.1007/s00467-013-2709-z24317637Search in Google Scholar

21Olie KH, Florquin S, Groothoff JW, Verlaak R, Strain L, Goodship TH, et al. Atypical relapse of hemolytic uremic syndrome after transplantation. Pediatr Nephrol. 2004; 19(10): 1173-1176.Olie KH Florquin S Groothoff JW Verlaak R Strain L Goodship TH et al Atypical relapse of hemolytic uremic syndrome after transplantation Pediatr Nephrol 2004 19 10 1173 117610.1007/s00467-004-1565-215300478Search in Google Scholar

22Olie KH, Goodship TH, Verlaak R, Florquin S, Groothoff JW, Strain L, et al. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: Successful treatment with intensive plasma exchanges and ganciclovir. Am J Kidney Dis. 2005; 45(1): e12-e15.Olie KH Goodship TH Verlaak R Florquin S Groothoff JW Strain L et al Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: Successful treatment with intensive plasma exchanges and ganciclovir Am J Kidney Dis 2005 45 1 e12 e1510.1053/j.ajkd.2004.09.01215696434Search in Google Scholar

23Davin JC, Strain L, Goodship TH. Plasma therapy in atypical haemolytic uremic syndrome: Lessons from a family with a factor H mutation. Pediatr Nephrol. 2008; 23(9): 1517-1521.Davin JC Strain L Goodship TH Plasma therapy in atypical haemolytic uremic syndrome: Lessons from a family with a factor H mutation Pediatr Nephrol 2008 23 9 1517 152110.1007/s00467-008-0833-y245923318483746Search in Google Scholar

24Lapeyraque AL, Wagner E, Phan V, Clermont MJ, Merouani A, Fremeaux-Bacchi V, et al. Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations. Pediatr Nephrol. 2008; 23(8): 1363-1366.Lapeyraque AL Wagner E Phan V Clermont MJ Merouani A Fremeaux-Bacchi V et al Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations Pediatr Nephrol 2008 23 8 1363 136610.1007/s00467-008-0803-418425537Search in Google Scholar

25Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, et al. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol. 2009; 24(4): 687-696.Ariceta G Besbas N Johnson S Karpman D Landau D Licht C et al Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome Pediatr Nephrol 2009 24 4 687 69610.1007/s00467-008-0964-118800230Search in Google Scholar

26Hidalgo M, Pinto S, Tortajada A, Rodríguez de Córdoba S. Genetics of atypical hemolytic uremic syndrome (aHUS). Semin Thromb Hemost. 2014; 40(04): 422-430.Hidalgo M Pinto S Tortajada A Rodríguez de Córdoba S Genetics of atypical hemolytic uremic syndrome (aHUS) Semin Thromb Hemost 2014 40 04 422 43010.1055/s-0034-137529624799305Search in Google Scholar

27Afshar-Kharghan V. Atypical hemolytic uremic syndrome. Hematology Am Soc Hematol Educ Program. 2016; 2016(1): 217-225.Afshar-Kharghan V Atypical hemolytic uremic syndrome Hematology Am Soc Hematol Educ Program 2016 2016 1 217 22510.1182/asheducation-2016.1.217614250927913483Search in Google Scholar

28Feitz WJC, van de Kar NCAJ, Orth-Höller D, van den Heuvel LPJW, Licht C. The genetics of atypical hemolytic uremic syndrome. Med Genet. 2018; 30 (4): 400-409.Feitz WJC van de Kar NCAJ Orth-Höller D van den Heuvel LPJW Licht C The genetics of atypical hemolytic uremic syndrome Med Genet 2018 30 4 400 40910.1007/s11825-018-0216-0640438930930551Search in Google Scholar

29Boon CJF, van de Kar NC, Klevering BJ, Keunen JEE, Cremers FPM, Klaver CCW, et al. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol. 2009; 46(8-9): 1573-1594.Boon CJF van de Kar NC Klevering BJ Keunen JEE Cremers FPM Klaver CCW et al The spectrum of phenotypes caused by variants in the CFH gene Mol Immunol 2009 46 8-9 1573 159410.1016/j.molimm.2009.02.01319297022Search in Google Scholar

30Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood. 2007; 110(5): 1516-1518.Józsi M Strobel S Dahse HM Liu WS Hoyer PF Oppermann M et al Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome Blood 2007 110 5 1516 151810.1182/blood-2007-02-07147217495132Search in Google Scholar

31Cody EM, Dixon BP. Hemolytic uremic syndrome. Pediatr Clin North Am. 2019; 66 (1): 235-246.Cody EM Dixon BP Hemolytic uremic syndrome Pediatr Clin North Am 2019 66 1 235 24610.1016/j.pcl.2018.09.01130454746Search in Google Scholar

32Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011; 8: 60-90.Loirat C Frémeaux-Bacchi V Atypical hemolytic uremic syndrome Orphanet J Rare Dis 2011 8 60 9010.1007/978-3-662-52972-0_24Search in Google Scholar

33Arjona E, Huerta A, Goicoechea de Jorge E, Rodríguez de Córdoba S. Familial risk of developing atypical hemolytic-uremic syndrome. Blood. 2020; 136(13): 1558-1561.Arjona E Huerta A Goicoechea de Jorge E Rodríguez de Córdoba S Familial risk of developing atypical hemolytic-uremic syndrome Blood 2020 136 13 1558 156110.1182/blood.202000693132488248Search in Google Scholar

34Sartz L, Olin AI, Kristoffersson AC, Ståhl AL, Johansson ME, Westman K, et al. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome. J Immunol. 2012; 188(4): 2030-2037.Sartz L Olin AI Kristoffersson AC Ståhl AL Johansson ME Westman K et al A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome J Immunol 2012 188 4 2030 203710.4049/jimmunol.110031922250080Search in Google Scholar

35Bhatia D, Khandelwal P, Sinha A, Hari P, Cheong HI, Bagga A. Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome. Pediatr Nephrol. 2015; 30(12): 2215-2220.Bhatia D Khandelwal P Sinha A Hari P Cheong HI Bagga A Incomplete penetrance of CD46 mutation causing familial atypical hemolytic uremic syndrome Pediatr Nephrol 2015 30 12 2215 222010.1007/s00467-015-3189-026307634Search in Google Scholar

36Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, et al. Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury. Am J Nephrol. 2018;48(3): 225-233.Cao M Leite BN Ferreiro T Calvo M Fernández C Alonso Á et al Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury Am J Nephrol 201848 3 225 23310.1159/00049286530205388Search in Google Scholar

37Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, et al. An international consensus approach to the management of atypical hemolytic uremic syndromein children. Pediatr Nephrol. 2016; 31(1):15-39.Loirat C Fakhouri F Ariceta G Besbas N Bitzan M Bjerre A et al An international consensus approach to the management of atypical hemolytic uremic syndromein children Pediatr Nephrol 2016 31 1 15 3910.1007/s00467-015-3076-825859752Search in Google Scholar

38Merrill SA, Brittingham ZD, Yuan X, Moliterno AR, Sperati CJ, Brodsky RA, et al. Eculizumab cessation in atypical hemolytic uremic syndrome. Blood. 2017; 130(3): 368-372.Merrill SA Brittingham ZD Yuan X Moliterno AR Sperati CJ Brodsky RA et al Eculizumab cessation in atypical hemolytic uremic syndrome Blood 2017 130 3 368 37210.1182/blood-2017-02-770214552047128461395Search in Google Scholar

39Ruszkowski J, Heleniak Z, Dębska-Ślizień A. Atypical hemolytic uremic syndrome: A new drug program and first Polish adult patient treated with eculizumab. Pol Merkur Lekarski. 2018; 45 (267): 119-121.Ruszkowski J Heleniak Z Dębska-Ślizień A Atypical hemolytic uremic syndrome: A new drug program and first Polish adult patient treated with eculizumab Pol Merkur Lekarski 2018 45 267 119 121Search in Google Scholar

40Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013; 368(23): 2169-2181.Legendre CM Licht C Muus P Greenbaum LA Babu S Bedrosian C et al Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome N Engl J Med 2013 368 23 2169 218110.1056/NEJMoa120898123738544Search in Google Scholar